Total Payments
$21,324
2024 Payments
$4,882
Companies
48
Transactions
629
Medicare Patients
18,938
Medicare Billing
$1.7M
Payment Breakdown by Category
Food & Beverage$15,079 (70.7%)
Research$4,000 (18.8%)
Other$1,210 (5.7%)
Travel$838.08 (3.9%)
Education$155.06 (0.7%)
Gifts$42.21 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,079 | 607 | 70.7% |
| Unspecified | $4,000 | 3 | 18.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,210 | 3 | 5.7% |
| Travel and Lodging | $838.08 | 6 | 3.9% |
| Education | $155.06 | 8 | 0.7% |
| Gift | $42.21 | 2 | 0.2% |
Payments by Type
General
$17,324
626 transactions
Research
$4,000
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,465 | 179 | $0 (2024) |
| UCB Biosciences Inc. | $4,000 | 3 | $0 (2019) |
| Janssen Biotech, Inc. | $1,299 | 75 | $0 (2024) |
| Medtronic, Inc. | $1,253 | 13 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,102 | 50 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $1,088 | 9 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $763.32 | 28 | $0 (2024) |
| Gilead Sciences, Inc. | $655.43 | 16 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $621.79 | 6 | $0 (2021) |
| Merck Sharp & Dohme LLC | $596.30 | 30 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,882 | 120 | Phathom Pharmaceuticals, Inc. ($1,088) |
| 2023 | $2,766 | 93 | AbbVie Inc. ($866.10) |
| 2022 | $2,213 | 95 | ABBVIE INC. ($757.11) |
| 2021 | $1,601 | 83 | AbbVie Inc. ($485.79) |
| 2020 | $1,024 | 51 | AbbVie Inc. ($458.00) |
| 2019 | $2,431 | 52 | UCB Biosciences Inc. ($1,000) |
| 2018 | $3,023 | 73 | UCB Biosciences Inc. ($1,000) |
| 2017 | $3,383 | 62 | UCB Biosciences Inc. ($2,000) |
All Payment Transactions
629 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/12/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: LIVER DISEASE | ||||||
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $4.23 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Immunology | ||||||
| 12/03/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $4.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/02/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.92 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/02/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 11/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Immunology | ||||||
| 11/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $8.87 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $124.83 | General |
| Category: Gastroenterology | ||||||
| 11/12/2024 | VIVUS LLC | QSYMIA (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/04/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $23.74 | General |
| Category: LIVER DISEASE | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Gastroenterology | ||||||
| 10/23/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $29.01 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/23/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/21/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $5.47 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/17/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: LIVER DISEASE | ||||||
| 10/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.64 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: Immunology | ||||||
| 10/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $9.74 | General |
| Category: IMMUNOLOGY | ||||||
| 10/01/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $15.75 | General |
| Category: GI | ||||||
| 09/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Non-Interventional, Long term, Post-Marketing Registry of Patients Treated with Certolizumab Pegol (CIMZIA) For Crohn's Disease | UCB Biosciences Inc. | $4,000 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 4,292 | 6,815 | $2.0M | $399,896 |
| 2022 | 22 | 5,401 | 9,468 | $2.8M | $510,798 |
| 2021 | 24 | 4,959 | 8,403 | $2.6M | $434,458 |
| 2020 | 23 | 4,286 | 6,904 | $2.3M | $381,637 |
Total Patients
18,938
Total Services
31,590
Medicare Billing
$1.7M
Procedure Codes
96
All Medicare Procedures & Services
96 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 700 | 2,175 | $435,000 | $107,374 | 24.7% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 1,526 | 1,632 | $261,120 | $56,093 | 21.5% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 333 | 671 | $196,603 | $52,789 | 26.9% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 239 | 405 | $119,475 | $28,588 | 23.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 125 | 125 | $160,125 | $24,570 | 15.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 271 | 318 | $68,688 | $19,368 | 28.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 133 | 166 | $52,124 | $14,423 | 27.7% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2023 | 83 | 209 | $54,131 | $12,422 | 22.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 68 | 68 | $64,600 | $11,786 | 18.2% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 87 | 93 | $102,672 | $10,145 | 9.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 180 | 186 | $196,230 | $9,126 | 4.7% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 108 | 146 | $30,660 | $8,170 | 26.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 48 | 48 | $45,648 | $6,389 | 14.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 33 | 33 | $31,416 | $5,731 | 18.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 46 | 46 | $55,890 | $5,705 | 10.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 79 | 79 | $24,569 | $5,221 | 21.2% |
| 76705 | Limited ultrasound scan of abdomen | Office | 2023 | 58 | 59 | $15,045 | $3,227 | 21.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $13,384 | $3,171 | 23.7% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 11 | 73 | $10,658 | $2,540 | 23.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 37 | $7,955 | $2,228 | 28.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 17 | 17 | $10,200 | $2,113 | 20.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 20 | 20 | $8,180 | $1,982 | 24.2% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 11 | 68 | $8,374 | $1,974 | 23.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 23 | 39 | $4,563 | $1,479 | 32.4% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 11 | 41 | $6,274 | $1,387 | 22.1% |
About Dr. Raymond Bedgood, D.O
Dr. Raymond Bedgood, D.O is a Gastroenterology healthcare provider based in Macon, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1881675700.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Raymond Bedgood, D.O has received a total of $21,324 in payments from pharmaceutical and medical device companies, with $4,882 received in 2024. These payments were reported across 629 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($15,079).
As a Medicare-enrolled provider, Bedgood has provided services to 18,938 Medicare beneficiaries, totaling 31,590 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 96 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Macon, GA
- Active Since 11/08/2005
- Last Updated 05/09/2019
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1881675700
Products in Payments
- Cimzia (Drug) $4,128
- STELARA (Biological) $1,558
- RINVOQ (Biological) $1,260
- INTERSTIM (Device) $1,218
- VOQUEZNA (Drug) $1,088
- XIFAXAN (Drug) $860.61
- OCALIVA (Drug) $763.32
- DUPIXENT (Biological) $724.95
- SKYRIZI (Biological) $650.71
- LINZESS (Drug) $604.38
- HUMIRA (Biological) $536.17
- Humira (Biological) $448.25
- DIFICID (Drug) $388.95
- XELJANZ (Drug) $319.17
- ZEPOSIA (Drug) $302.48
- IBSRELA (Drug) $284.39
- ENTYVIO (Biological) $281.50
- REMICADE (Biological) $271.27
- GIMOTI (Drug) $261.60
- Epclusa (Drug) $246.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Macon
Dr. Daniel Penn, M.d, M.D
Gastroenterology — Payments: $196,237
Gastroenterology $196,237
Dr. Adam Levy, M.d, M.D
Gastroenterology — Payments: $74,787
Gastroenterology $74,787
Joel Judah, Md, MD
Gastroenterology — Payments: $13,591
Gastroenterology $13,591
Carley Ebanks, M.d, M.D
Gastroenterology — Payments: $8,960
Gastroenterology $8,960
Dr. William Fackler, Md, MD
Gastroenterology — Payments: $7,328
Gastroenterology $7,328
Shahriar Sedghi, M.d, M.D
Gastroenterology — Payments: $7,263
Gastroenterology $7,263